← Eichor
Study identifier: NCT07058935 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)

Condition: Valve Disease, Heart  ·  Sponsor: National Heart Centre Singapore

PhaseN/A
Planned participants150
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.

This description comes directly from the study's public registry record.

Talk to the study team

Deborah Yip  ·  +65-67042301  ·  deborah.yip.x.y@singhealth.com.sg

Always discuss trial participation with your own doctor first.

Locations (8)

John Hunter HospitalNew Lambton Heights, AustraliaNot Yet Recruiting
Prince of Wales HospitalHong Kong, Hong KongNot Yet Recruiting
Queen Elizabeth HospitalHong Kong, Hong KongNot Yet Recruiting
MGM Healthcare Pvt LtdChennai, Tamil Nadu, IndiaNot Yet Recruiting
The Madras Medical MissionChennai, Tamil Nadu, IndiaNot Yet Recruiting
Waikato HospitalHamilton, New ZealandNot Yet Recruiting
National Heart Centre SingaporeSingapore, SingaporeRecruiting
Ramathibodi HospitalBangkok, ThailandNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07058935